Susan Altschuller

Director of Finance/CFO presso CEREVEL THERAPEUTICS HOLDINGS, INC.

Patrimonio netto: 714 913 $ in data 31/03/2024

42 anni

81 relazioni

Health Technology

Consumer Services

Process Industries

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Caroline Loew	M	54		1 anni
James Collins	M	62	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	1 anni
Gabrielle Greene-Sulzberger	F	63	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	5 anni
Suneet Varma	M	55	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	2 anni
Deborah Baron	F	55	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	3 anni
Adam Koppel	M	54	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	6 anni
Christopher Gordon	M	51	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	6 anni
Ronald Renaud	M	55	CEREVEL THERAPEUTICS HOLDINGS, INC.	1 anni
N. Coles	M	63	CEREVEL THERAPEUTICS HOLDINGS, INC.	6 anni
Norbert Riedel	M	66	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	6 anni
Marijn Dekkers	M	65	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	6 anni
Deval Patrick	M	67	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	4 anni
Ruth McKernan	M	66	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	4 anni
Juan Estupinan	M	-	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	2 anni
Douglas Giordano	M	61	CEREVEL THERAPEUTICS HOLDINGS, INC. Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.	6 anni
Benjamin Hickey	M	50		1 anni
Kathleen Tregoning	F	53	CEREVEL THERAPEUTICS HOLDINGS, INC.	4 anni
Scott Akamine	M	40	CEREVEL THERAPEUTICS HOLDINGS, INC.	3 anni
Gianluca Pirozzi	M	47	ALEXION PHARMACEUTICALS, INC.	5 anni
Daniel Char	M	63	IMMUNOGEN, INC.	2 anni
Maiken Keson-Brookes	F	52		1 anni
Robert M. Kennedy	M	-	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	15 anni
Mark Bodenrader	M	51	CEREVEL THERAPEUTICS HOLDINGS, INC.	5 anni
Adam Daniel Cutler	M	50		1 anni
Francis Cuss	M	69		1 anni
Vicki Goodman	M	55		1 anni
Kartik Dharmadhikari	M	-	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	4 anni
Anna Robinson	F	-	CEREVEL THERAPEUTICS HOLDINGS, INC.	-
Tamar Thompson	F	50	ALEXION PHARMACEUTICALS, INC.	5 anni
Raymond Sanchez	M	63	CEREVEL THERAPEUTICS HOLDINGS, INC.	5 anni
Kenneth DiPietro	M	65	CEREVEL THERAPEUTICS HOLDINGS, INC.	5 anni
Adam Wieschhaus	M	41	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	3 anni
John Renger	M	55	CEREVEL THERAPEUTICS HOLDINGS, INC.	5 anni
Jason Noel	M	-	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	5 anni
Paul Burgess	M	50	CEREVEL THERAPEUTICS HOLDINGS, INC.	1 anni
Mary Margaret Huizinga	M	47	IMMUNOGEN, INC.	2 anni
Matthew Calistri	M	-	CEREVEL THERAPEUTICS HOLDINGS, INC.	-
Philip Austin	M	-	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	10 anni
Ron L. Meeusen	M	72	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	-
Scott Jackson	M	59		1 anni
Ariel Barack	M	-	Vestaron Corp. Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.	2 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
David G. Foster	M	-	IMMUNOGEN, INC.	3 anni
Helen Thackray	M	55	IMMUNOGEN, INC.	3 anni
Tina Beamon	F	-	ALEXION PHARMACEUTICALS, INC.	3 anni
Thomas Ryll	M	64	IMMUNOGEN, INC.	6 anni
Judith Reinsdorf	F	60	ALEXION PHARMACEUTICALS, INC.	3 anni
John C. King	M	49	ALEXION PHARMACEUTICALS, INC.	9 anni
Michael V. Greco	M	53	ALEXION PHARMACEUTICALS, INC.	11 anni
Tracey McCain	F	56	IMMUNOGEN, INC.	3 anni
Deborah Dunsire	M	61	ALEXION PHARMACEUTICALS, INC.	3 anni
Ellen Chiniara	F	65	ALEXION PHARMACEUTICALS, INC.	3 anni
Alvin S. Parven	M	83	ALEXION PHARMACEUTICALS, INC.	19 anni
M. Burns	F	66	ALEXION PHARMACEUTICALS, INC.	4 anni
Elena Ridloff	F	44	ALEXION PHARMACEUTICALS, INC.	4 anni
Uzair Qadeer	M	-	ALEXION PHARMACEUTICALS, INC.	2 anni
Kristen Stants	F	51	ALEXION PHARMACEUTICALS, INC.	2 anni
Adam Hansard	M	48	ALEXION PHARMACEUTICALS, INC.	1 anni
Mohammed Qatanani	M	50	ALEXION PHARMACEUTICALS, INC.	3 anni
Matthew DeLawder	M	-	ALEXION PHARMACEUTICALS, INC.	5 anni
Julia Wang	F	53	ALEXION PHARMACEUTICALS, INC.	2 anni
Lisa Trivison Beck	F	62	ALEXION PHARMACEUTICALS, INC.	3 anni
Christopher Benecchi	M	-	ALEXION PHARMACEUTICALS, INC.	2 anni
Kristen Harrington-Smith	F	51	IMMUNOGEN, INC.	1 anni
Thierry Chauche	M	48	ALEXION PHARMACEUTICALS, INC.	1 anni
Christopher Wick	M	-	ALEXION PHARMACEUTICALS, INC.	4 anni
Kenny Chan	M	-	ALEXION PHARMACEUTICALS, INC.	-
Brian Krex	M	57	ALEXION PHARMACEUTICALS, INC.	4 anni
Jens Renstrup	M	59	ALEXION PHARMACEUTICALS, INC.	3 anni
Paul Clancy	M	62	ALEXION PHARMACEUTICALS, INC.	2 anni
Jacques Suzanne	F	53	ALEXION PHARMACEUTICALS, INC.	2 anni
Matthew Batters	M	48	ALEXION PHARMACEUTICALS, INC.	4 anni
Jose Menoyo	M	-	ALEXION PHARMACEUTICALS, INC.	3 anni
Julie O'Neill	F	58	ALEXION PHARMACEUTICALS, INC.	3 anni
Jing Marantz	M	59	ALEXION PHARMACEUTICALS, INC.	2 anni
Christopher J. Stevo	M	-	ALEXION PHARMACEUTICALS, INC.	1 anni
Steven Ryder	M	73	ALEXION PHARMACEUTICALS, INC.	5 anni
John Moriarty	M	56	ALEXION PHARMACEUTICALS, INC.	6 anni
Tanisha Cariño	M	49	ALEXION PHARMACEUTICALS, INC.	2 anni
Heidi Wagner	F	59	ALEXION PHARMACEUTICALS, INC.	9 anni
Camille Bedrosian	M	71	ALEXION PHARMACEUTICALS, INC.	10 anni
Laura Gault	F	-	ALEXION PHARMACEUTICALS, INC.	3 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	74	91.36%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni